-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Mar 14, 16:00Prev. Close
396.55
Open Price
395.10
Bid Price (Qty.)
395.00 (1000)
Offer Price (Qty.)
396.55 (187)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Claris Lifesciences (in Rs. Cr.) | Dec 06 | Dec 05 | |
| 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 83.81 | 28.44 | |
| Net CashFlow From Operating Activities | 42.46 | 19.75 | |
| Net Cash Used In Investing Activities | -147.61 | -47.13 | |
| Net Cash Used From Financing Activities | 170.69 | 36.18 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 65.55 | 8.80 | |
| Cash And Cash Equivalents Begin of Year | 10.88 | 2.08 | |
| Cash And Cash Equivalents End Of Year | 76.43 | 10.88 |
03.12.2017
17.10.2017
31.07.2017
US FDA conducts surprise audit at Claris Life's Ahmedabad unit
27.07.2017
Claris completes injectables biz sale, to inform about transfer to shareholders by Oct
